Diamond Blackfan Anemia 8 C2675511
A rare genetic blood disorder where bone marrow fails to produce enough red blood cells. Usually appears in infancy and is treated with medications, transfusions, or stem cell transplant.
Key facts at a glance
- ICD-10
- D64.9
- ICD-11
- 3A00.0
- Body system
- hematologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(hematologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Anemia
(hematologic)Exercise intolerance
(hematologic)Reticulocytopenia
(hematologic)Growth retardation
(cardiovascular)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Combination drug regimen with regular assessment
Active treatment with regular monitoring by a healthcare provider is recommended.
Corticosteroid therapy
Corticosteroids serve as primary treatment to enhance red blood cell production in Diamond-Blackfan anemia type 8. Treatment response should be assessed within the first month of initiation with appropriate laboratory monitoring.
Red blood cell transfusion support
Transfusion therapy maintains hemoglobin levels above symptomatic thresholds when steroid therapy is ineffective or contraindicated. Individualized transfusion intervals help balance quality of life with iron accumulation risks.
Additional treatment options
Comprehensive disease monitoring
Regular monitoring of hematologic parameters, iron studies, growth metrics, and endocrine function helps guide treatment decisions and detect complications early. Imaging studies assess organ iron loading.
monitoringHematopoietic stem cell transplantation
Allogeneic stem cell transplantation provides a curative option for eligible patients with matched donors. Pre-transplant evaluation includes cardiac function assessment and iron burden analysis.
surgicalSupportive care and quality of life management
Integrative supportive approaches including stress management, adequate rest, and complementary therapies help manage fatigue and improve overall well-being alongside disease-specific treatments.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Diamond Blackfan Anemia 8 C2675511?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Diamond Blackfan Anemia 8 C2675511. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy